{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:59:06Z","timestamp":1793069946255,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Plan of Liaoning Province","award":["2021-MS-277"],"award-info":[{"award-number":["2021-MS-277"]}]},{"name":"the Scientific research funds of Liaoning Provincial Department of Education"},{"name":"\u201c1+X\u201d plan project","award":["2022LCJSZD04"],"award-info":[{"award-number":["2022LCJSZD04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To determine the recurrence rate in the women with controlled ovarian hyperstimulation after a history of borderline ovarian tumors (BOT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective analysis of 275 patients with BOT undergoing surgery for fertility preservation in our hospital between 2001 and 2017. Cases were divided into an assisted reproductive technology (ART) treatment group (n\u2009=\u200915) and a non-ART treatment group (n\u2009=\u2009260). We compared the recurrence rate, survival rate and pregnancy outcomes between these two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The ART group had a higher recurrence rate (33.33% vs. 10.80%, P\u2009=\u20090.023). Survival analysis indicated that the recurrence time in patients undergoing ART was significantly shorter (P\u2009=\u20090.026). A low pregnancy rate before diagnosis, and high intraoperative blood loss, were associated with postoperative ART treatment (P\u2009&lt;\u20090.05). Multivariate analysis showed that ART treatment and bilateral lesions both significantly increased the risk of recurrence (P\u2009&lt;\u20090.05). The pathological type of recurrent tumors was often the same as the initial tumor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The postoperative use of ART in patients with BOT significantly increased the recurrence rate, but does not significantly affect the overall survival rate of patients. Therefore, ART in such patients should be individualized, and close follow-up is necessary after ART.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-023-07103-8","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T05:02:27Z","timestamp":1695704547000},"page":"1515-1523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?"],"prefix":"10.1007","volume":"309","author":[{"given":"Han","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-6497","authenticated-orcid":false,"given":"Heng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-4475","authenticated-orcid":false,"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"issue":"6","key":"7103_CR1","first-page":"368","volume":"11","author":"HC Taylor","year":"1935","unstructured":"Taylor HC (1935) Benign and malignant lesions of the female reproductive tract. Bull N Y Acad Med 11(6):368\u2013382","journal-title":"Bull N Y Acad Med"},{"key":"7103_CR2","doi-asserted-by":"crossref","unstructured":"General Assembly of FIGO (1971) Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand. 50(1):1\u20137","DOI":"10.3109\/00016347109157278"},{"issue":"Suppl 2","key":"7103_CR3","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/S0893-3952(22)04457-X","volume":"18","author":"WR Hart","year":"2005","unstructured":"Hart WR (2005) Borderline epithelial tumors of the ovary. Mod Pathol 18(Suppl 2):S33-50","journal-title":"Mod Pathol"},{"issue":"3","key":"7103_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bpobgyn.2011.12.006","volume":"26","author":"CG Trope","year":"2012","unstructured":"Trope CG, Kaern J, Davidson B (2012) Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol 26(3):325\u2013336","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"7103_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ygyno.2006.10.001","volume":"104","author":"M Cusido","year":"2007","unstructured":"Cusido M, Balaguero L, Hernandez G, Falcon O, Rodriguez-Escudero FJ, Vargas JA, Vidart JA, Zamora L, Monera M, Alonso A, Section of Gynecologic O, Breast Pathology of Spanish Federation of Gynecologic O (2007) Results of the national survey of borderline ovarian tumors in Spain. Gynecol Oncol 104(3):617\u2013622","journal-title":"Gynecol Oncol"},{"issue":"Suppl","key":"7103_CR6","first-page":"S13","volume":"123","author":"G Acs","year":"2005","unstructured":"Acs G (2005) Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 123(Suppl):S13-57","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"7103_CR7","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0015-0282(03)00160-2","volume":"79","author":"J Donnez","year":"2003","unstructured":"Donnez J, Munschke A, Berliere M, Pirard C, Jadoul P, Smets M, Squifflet J (2003) Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril 79(5):1216\u20131221","journal-title":"Fertil Steril"},{"issue":"5","key":"7103_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0015-0282(01)02842-4","volume":"76","author":"R Seracchioli","year":"2001","unstructured":"Seracchioli R, Venturoli S, Colombo FM, Govoni F, Missiroli S, Bagnoli A (2001) Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril 76(5):999\u20131004","journal-title":"Fertil Steril"},{"issue":"7\u20138","key":"7103_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1297-9589(02)00380-6","volume":"30","author":"S Camatte","year":"2002","unstructured":"Camatte S, Rouzier R, Boccara-Dekeyser J, Pautier P, Pomel C, Lhomme C, Duvillard P, Castaigne D, Morice P (2002) Prognosis and fertility after conservative treatment for ovarian tumors of limited malignity: review of 68 cases. Gynecol Obstet Fertil 30(7\u20138):583\u2013591","journal-title":"Gynecol Obstet Fertil"},{"issue":"10","key":"7103_CR10","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/oxfordjournals.aje.a116428","volume":"136","author":"R Harris","year":"1992","unstructured":"Harris R, Whittemore AS, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136(10):1204\u20131211","journal-title":"Am J Epidemiol"},{"issue":"3","key":"7103_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1006\/gyno.1997.4928","volume":"68","author":"F Parazzini","year":"1998","unstructured":"Parazzini F, Negri E, La Vecchia C, Moroni S, Polatti A, Chiaffarino F, Surace M, Ricci E (1998) Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol Oncol 68(3):226\u2013228","journal-title":"Gynecol Oncol"},{"issue":"4","key":"7103_CR12","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.fertnstert.2008.01.073","volume":"91","author":"K Sanner","year":"2009","unstructured":"Sanner K, Conner P, Bergfeldt K, Dickman P, Sundfeldt K, Bergh T, Hagenfeldt K, Janson PO, Nilsson S, Persson I (2009) Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil Steril 91(4):1152\u20131158","journal-title":"Fertil Steril"},{"issue":"1","key":"7103_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0015-0282(16)58020-0","volume":"65","author":"A Shushan","year":"1996","unstructured":"Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG (1996) Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 65(1):13\u201318","journal-title":"Fertil Steril"},{"issue":"12","key":"7103_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJM199409223311204","volume":"331","author":"MA Rossing","year":"1994","unstructured":"Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331(12):771\u2013776","journal-title":"N Engl J Med"},{"issue":"6","key":"7103_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0015-0282(98)00337-9","volume":"70","author":"BJ Mosgaard","year":"1998","unstructured":"Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN (1998) Ovarian stimulation and borderline ovarian tumors: a case-control study. Fertil Steril 70(6):1049\u20131055","journal-title":"Fertil Steril"},{"issue":"7","key":"7103_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/09513590701350341","volume":"23","author":"M Cusido","year":"2007","unstructured":"Cusido M, Fabregas R, Pere BS, Escayola C, Barri PN (2007) Ovulation induction treatment and risk of borderline ovarian tumors. Gynecol Endocrinol 23(7):373\u2013376","journal-title":"Gynecol Endocrinol"},{"issue":"12","key":"7103_CR17","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1093\/humrep\/der322","volume":"26","author":"FE van Leeuwen","year":"2011","unstructured":"van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, Jansen CA, Helmerhorst FM, Cohlen BJ, Willemsen WN, Smeenk JM, Simons AH, van der Veen F, Evers JL, van Dop PA, Macklon NS, Burger CW (2011) Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod 26(12):3456\u20133465","journal-title":"Hum Reprod"},{"issue":"4","key":"7103_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/humupd\/6.4.318","volume":"6","author":"R Ron-El","year":"2000","unstructured":"Ron-El R, Raziel A, Schachter M, Strassburger D, Kasterstein E, Friedler S (2000) Induction of ovulation after gnRH antagonists. Hum Reprod Update 6(4):318\u2013321","journal-title":"Hum Reprod Update"},{"issue":"4","key":"7103_CR19","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.18632\/oncotarget.13967","volume":"8","author":"J Lu","year":"2017","unstructured":"Lu J, Tao X, Zhou J, Lu Y, Wang Z, Liu H, Xu C (2017) Improved clinical outcomes of patients with ovarian carcinoma arising in endometriosis. Oncotarget 8(4):5843\u20135852","journal-title":"Oncotarget"},{"issue":"11","key":"7103_CR20","first-page":"6725","volume":"34","author":"A Lazarou","year":"2014","unstructured":"Lazarou A, Fotopoulou C, Coumbos A, Sehouli J, Vasiljeva J, Braicu I, Burger H, Kuehn W (2014) Long-term follow-up of borderline ovarian tumors clinical outcome and prognostic factors. Anticancer Res 34(11):6725\u20136730","journal-title":"Anticancer Res"},{"key":"7103_CR21","first-page":"CD008215","volume":"8","author":"I Rizzuto","year":"2013","unstructured":"Rizzuto I, Behrens RF, Smith LA (2013) Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev 8:CD008215","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"7103_CR22","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/oxfordjournals.aje.a116429","volume":"136","author":"AS Whittemore","year":"1992","unstructured":"Whittemore AS, Harris R, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer Collaborative Ovarian Cancer Group. Am J Epidemiol 136(10):1212\u20131220","journal-title":"Am J Epidemiol"},{"issue":"3","key":"7103_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/aje\/155.3.217","volume":"155","author":"RB Ness","year":"2002","unstructured":"Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, Risch HA, Vergona R, Wu AH (2002) Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 155(3):217\u2013224","journal-title":"Am J Epidemiol"},{"issue":"1","key":"7103_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0301-2115(98)00285-1","volume":"85","author":"A Shushan","year":"1999","unstructured":"Shushan A, Paltiel O, Schenker JG (1999) Induction of ovulation and borderline ovarian cancer\u2013the hormonal connection? Eur J Obstet Gynecol Reprod Biol 85(1):71\u201374","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"7103_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/humrep\/deu297","volume":"30","author":"SM Bjornholt","year":"2015","unstructured":"Bjornholt SM, Kjaer SK, Nielsen TS, Jensen A (2015) Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study. Hum Reprod 30(1):222\u2013231","journal-title":"Hum Reprod"},{"issue":"Suppl","key":"7103_CR26","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.3346\/jkms.2007.22.S.S134","volume":"22","author":"CW Park","year":"2007","unstructured":"Park CW, Yang KM, Kim HO, Hong SR, Kim TJ, Lim KT, Lee KH, Kang IS (2007) Outcomes of controlled ovarian hyperstimulation\/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment. J Korean Med Sci 22(Suppl):S134-138","journal-title":"J Korean Med Sci"},{"issue":"12","key":"7103_CR27","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/0959-8049(92)90240-3","volume":"28A","author":"HW Nijman","year":"1992","unstructured":"Nijman HW, Burger CW, Baak JP, Schats R, Vermorken JB, Kenemans P (1992) Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases. Eur J Cancer 28A(12):1971\u20131973","journal-title":"Eur J Cancer"},{"issue":"11","key":"7103_CR28","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/oxfordjournals.humrep.a138388","volume":"9","author":"T Mantzavinos","year":"1994","unstructured":"Mantzavinos T, Kanakas N, Genatas C, Papadias K, Zourlas PA (1994) Five years\u2019 follow-up in two patients with borderline tumours of the ovary hyperstimulated by gonadotrophin therapy for in-vitro fertilization. Hum Reprod 9(11):2032\u20132033","journal-title":"Hum Reprod"},{"issue":"3","key":"7103_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1006\/gyno.1999.5488","volume":"74","author":"JS Hoffman","year":"1999","unstructured":"Hoffman JS, Laird L, Benadiva C, Dreiss R (1999) In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary. Gynecol Oncol 74(3):515\u2013518","journal-title":"Gynecol Oncol"},{"issue":"1","key":"7103_CR30","first-page":"64","volume":"25","author":"J Abboud","year":"1997","unstructured":"Abboud J, Attieh E, Atallah D, Kessrouani A, Chaoul G (1997) Three cases of ovarian cancer after ovulation induction for infertility. Contracept Fertil Sex 25(1):64\u201365","journal-title":"Contracept Fertil Sex"},{"issue":"2","key":"7103_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/1097-0142(20010715)92:2<320::AID-CNCR1325>3.0.CO;2-G","volume":"92","author":"ME Beiner","year":"2001","unstructured":"Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G (2001) Infertility treatment after conservative management of borderline ovarian tumors. Cancer 92(2):320\u2013325","journal-title":"Cancer"},{"issue":"6","key":"7103_CR32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jcma.2011.04.003","volume":"74","author":"HW Tsai","year":"2011","unstructured":"Tsai HW, Ko CC, Yeh CC, Chen YJ, Twu NF, Chao KC, Yen MS (2011) Unilateral salpingo-oophorectomy as fertility-sparing surgery for borderline ovarian tumors. J Chin Med Assoc 74(6):250\u2013254","journal-title":"J Chin Med Assoc"},{"issue":"4","key":"7103_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1245\/ASO.2006.12.024","volume":"13","author":"C Poncelet","year":"2006","unstructured":"Poncelet C, Fauvet R, Boccara J, Darai E (2006) Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study. Ann Surg Oncol 13(4):565\u2013571","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7103_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.fertnstert.2006.11.128","volume":"88","author":"Y Yinon","year":"2007","unstructured":"Yinon Y, Beiner ME, Gotlieb WH, Korach Y, Perri T, Ben-Baruch G (2007) Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors. Fertil Steril 88(2):479\u2013484","journal-title":"Fertil Steril"},{"key":"7103_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejogrb.2021.12.029","volume":"269","author":"P Sobiczewski","year":"2022","unstructured":"Sobiczewski P, Piatek S, Michalski W et al (2022) Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: a single center experience. Eur J Obstet Gynecol Reprod Biol 269:126\u2013131","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"13","key":"7103_CR36","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.3390\/jcm11133645","volume":"11","author":"A Ozenne","year":"2022","unstructured":"Ozenne A, De Berti M, Body G et al (2022) Risk factors for recurrence of borderline ovarian tumours after conservative surgery and impact on fertility: a multicentre study by the Francogyn group. J Clin Med 11(13):3645","journal-title":"J Clin Med"},{"issue":"1","key":"7103_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ygyno.2019.12.046","volume":"157","author":"A Chevrot","year":"2020","unstructured":"Chevrot A, Pouget N, Bats AS et al (2020) Fertility and prognosis of borderline ovarian tumor after conservative management: results of the multicentric OPTIBOT study by the GINECO & TMRG group. Gynecol Oncol 157(1):29\u201335","journal-title":"Gynecol Oncol"},{"issue":"7","key":"7103_CR38","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/annonc\/mdu160","volume":"25","author":"J Prat","year":"2014","unstructured":"Prat J (2014) The results of conservative (fertility-sparing) treatment in borderline ovarian tumors vary depending on age and histological type. Ann Oncol 25(7):1255\u20131258","journal-title":"Ann Oncol"},{"issue":"5","key":"7103_CR39","first-page":"488","volume":"32","author":"T Tao","year":"2010","unstructured":"Tao T, Cao DY, Yang JX, Shen K, Lang JH, Guo LN (2010) Prognostic factors and fertility outcomes of borderline ovarian tumors after conservative surgery. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 32(5):488\u2013492","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07103-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-023-07103-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07103-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T10:06:01Z","timestamp":1708769161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-023-07103-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["7103"],"URL":"https:\/\/doi.org\/10.1007\/s00404-023-07103-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2292545\/v1","asserted-by":"object"}]},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"19 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a retrospective study. The Research Ethics Committee has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}